HBW Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$397K Sell
2,507
-9
-0.4% -$1.22K 0.04% 337
2026
Q1
$321K Buy
+2,516
New +$314K 0.03% 350
2021
Q1
Sell
-1,701
Closed -$239K 274
2020
Q4
$239K Buy
+1,701
New +$218K 0.07% 192
2020
Q1
Sell
-5,458
Closed -$519K 152
2019
Q4
$519K Buy
+5,458
New +$472K 0.3% 81

Other funds holding XBI

HBW Advisory Services's XBI Position: Q2 2026 in Review

HBW Advisory Services reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.36% in Q2 2026, selling an estimated $1.22K and leaving 2,507 shares worth $397K. The position accounts for 0.04% of the portfolio, ranked #337.

HBW Advisory Services first reported a position in XBI in Q4 2019 and has held it in 4 quarters since. The position peaked at $519K in Q4 2019. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • HBW Advisory Services held 2,507 shares of State Street SPDR S&P Biotech ETF worth $397K as of Q2 2026.
  • HBW Advisory Services sold 9 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.22K.
  • State Street SPDR S&P Biotech ETF made up 0.04% of HBW Advisory Services's portfolio in Q2 2026, its #337 holding.
  • HBW Advisory Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 4 quarters since.
  • HBW Advisory Services's State Street SPDR S&P Biotech ETF position peaked at $519K in Q4 2019.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on HBW Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.